1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow MaxCyte, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma MCY-M11, Cyclophosphamide - Peritoneal Mesothelioma, Fallopian Tube Adenocarcinoma | Phase 1 | Terminated | MaxCyte, Inc. | 14 | 2018-08-27 | 2021-09-05 |
Cyclophosphamide (1)
United States (1)